An update from Syncona Shs GBP ( (GB:SYNC) ) is now available.
Syncona Limited announced the purchase of 150,000 of its ordinary shares as part of its ongoing share buyback program. The shares were bought at a consistent price of 93.6764 GBp each and will be held in treasury, reducing the total voting rights to 619,045,995. This move is part of Syncona’s strategy to manage its capital structure effectively, potentially enhancing shareholder value and maintaining its market position.
More about Syncona Shs GBP
Syncona Limited is a prominent life science investor focused on creating, building, and scaling a portfolio of global leaders in the life sciences. The company aims to develop transformational treatments for patients with high unmet needs by partnering with world-class academic founders and experienced management teams. Syncona maintains a diversified portfolio of 20-25 leading life science businesses across various development stages, modalities, and therapeutic areas, with a long-term strategy to deliver strong risk-adjusted returns to shareholders.
YTD Price Performance: -12.69%
Average Trading Volume: 746,947
Technical Sentiment Consensus Rating: Buy
For a thorough assessment of SYNC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com